Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 4/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | ERN1 | O75460 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 5/20 | 0.33 |
| ▸ | USP7 | Q93009 | 1/20 | 0.33 |
| ▸ | IKBKB | O14920 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4519234 | 0.81 | TSHR (0.44) | NPC1RAB9AMEN1KMT2AGRM5 | |
| SCHEMBL32681308 | 0.80 | ERN1 (0.40) | NPC1RAB9AMEN1KMT2AERN1 | |
| SCHEMBL4520641 | 0.77 | P2RY6 (0.40) | PDK1CYP3A4TSHRALDH1A1 | |
| SCHEMBL4524383 | 0.77 | PDK1 (0.33) | MEN1KMT2APDK1CYP3A4TSHR | |
| SCHEMBL4519084 | 0.74 | ERN1 (0.45) | HCRTR1NPC1RAB9AERN1GRM5 | |
| SCHEMBL4524088 | 0.73 | ACACB (0.44) | MEN1KMT2ATSHRALDH1A1 | |
| SCHEMBL4519930 | 0.73 | FFAR1 (0.42) | NPC1RAB9AMEN1KMT2AGRM5 | |
| SCHEMBL4525918 | 0.72 | MAPT (0.39) | NPC1RAB9APOLBCYP3A4ALDH1A1 | |
| SCHEMBL4519091 | 0.72 | VCAM1 (0.33) | GRM5USP7ALDH1A1 | |
| SCHEMBL4531614 | 0.72 | FFAR1 (0.39) | NPC1RAB9AMEN1KMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7566773-B2 | Photolabile compound and substrate for oligomer probe array with the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2009-07-28 | — | — | US | disclosed |
| US-20080057489-A1 | Photolabile Compound and Substrate for Oligomer Probe Array with the Same | SAMSUNG ELECTRONICS CO., LTD (KR) | 2008-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080057489-A1 | Photolabile Compound and Substrate for Oligomer Probe Array with the Same | APBA1, B3GNT2, PCNA | HCRTR1 3963/4885NPC1 3839/4885RAB9A 4580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.